Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Finch Therapeutics Group (FNCH)
NASDAQ:FNCH
Finch Therapeutics Group (FNCH) Ownership - Who Owns Finch Therapeutics Group?
49 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 29, 2024 | Jeffery Smisek Director | Sold | $21246 |
| Nov 27, 2023 | Jeffery Smisek Director | Sold | $5351 |
| Jun 09, 2023 | Susan Graf Director | Bought | $1353 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 67,296 | Institution | 4.19% | 187,621 | |
| 38,764 | Institution | 2.41% | 108,074 | |
| 36,252 | Institution | 2.26% | 101,071 | |
| 7,497 | Institution | 0.47% | 20,902 | |
| 6,402 | Institution | 0.40% | 17,849 | |
| 124 | Institution | <0.01% | 346 | |
| 0 | Institution | <0.01% | 1 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 38,764 | Institution | 2.41% | 108,074 | |
| 7,497 | Institution | 0.47% | 20,902 | |
| 6,402 | Institution | 0.40% | 17,849 | |
| 124 | Institution | <0.01% | 346 | |
| 0 | Institution | <0.01% | 1 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 20,018 | Institution | 1.25% | 52,647 | |
| 16,234 | Institution | 1.01% | 42,695 |
FAQ
Who Owns Finch Therapeutics Group (FNCH)?
Currently, no data Available
What percentage of Finch Therapeutics Group (FNCH) stock is held by institutional investors?
Currently, no data Available
What percentage of Finch Therapeutics Group (FNCH) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Finch Therapeutics Group (FNCH)?
Seth Klarman owns the most shares of Finch Therapeutics Group (FNCH).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.